Background: Although intravenous recombinant tissue plasminogen activator (rt-PA) thrombolysis is the most effective early treatment for acute ischemic stroke (AIS), outcomes vary greatly among patients. The gene discussed is PLAT; the disease is androgen insensitivity syndrome.